OPINION SMITH, Chief Judge. This opinion addresses two sets of consolidated appeals concerning two pharmaceutical drugs: Lipitor and Effexor XR. In both sets of consolidated appeals, plaintiffs allege that the companies holding the patents related to Lipitor and Effexor XR fraudulently procured and enforced certain of those patents. Plaintiffs further all

Court of Appeals for the Third Circuit · 868 F.3d 231 · 2017-08-21

Key topics: contract, corporation, antitrust, securities, business, tort, partnership.

Public court record summarized from official/open sources. Read the court record and full opinion (PDF).